(株)医学生物学研究所の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証JQS | 医薬品 | 4557/E00978 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/09/27 | 日証協 | 122,945株 | +1.91% | 36,000株 | -28.97% | 108,146株 | +0.58% | 38,115株 | +56.11% |
2019/09/20 | 日証協 | 120,645株 | -0.75% | 50,684株 | -0.94% | 107,527株 | -5.87% | 24,416株 | -28.93% |
2019/09/13 | 日証協 | 121,561株 | +23.98% | 51,164株 | -13.72% | 114,232株 | +4.98% | 34,356株 | -13.94% |
2019/09/06 | 日証協 | 98,045株 | -11.39% | 59,300株 | +35.08% | 108,811株 | -1.85% | 39,922株 | +84.57% |
2019/08/30 | 日証協 | 110,645株 | -15.7% | 43,900株 | +111.52% | 110,862株 | +20.93% | 21,630株 | +66.13% |
2019/08/23 | 日証協 | 131,245株 | -14.3% | 20,755株 | +25.79% | 91,673株 | -15.94% | 13,020株 | -14.36% |
2019/08/16 | 日証協 | 153,145株 | +2% | 16,500株 | -40.48% | 109,061株 | +14.26% | 15,203株 | -37.48% |
2019/08/09 | 日証協 | 150,145株 | +26.75% | 27,722株 | -53.95% | 95,451株 | +28.2% | 24,318株 | -34.66% |
2019/08/02 | 日証協 | 118,461株 | +4.87% | 60,200株 | +386.9% | 74,452株 | +6.57% | 37,215株 | +672.74% |
2019/07/26 | 日証協 | 112,961株 | -6.91% | 12,364株 | +35.39% | 69,865株 | -5.39% | 4,816株 | +128.9% |
2019/07/19 | 日証協 | 121,345株 | +1.51% | 9,132株 | -72.61% | 73,849株 | +2.08% | 2,104株 | -44.73% |
2019/07/12 | 日証協 | 119,545株 | -19.63% | 33,339株 | +22.3% | 72,343株 | -27.76% | 3,807株 | +137.2% |
2019/07/05 | 日証協 | 148,745株 | +1.5% | 27,260株 | -31.09% | 100,138株 | +1.51% | 1,605株 | -71.35% |
2019/06/28 | 日証協 | 146,545株 | -5.6% | 39,560株 | -4.91% | 98,648株 | -3.59% | 5,603株 | -81.01% |
2019/06/21 | 日証協 | 155,245株 | +4.72% | 41,602株 | +7.78% | 102,320株 | +15.27% | 29,500株 | +158.61% |
2019/06/14 | 日証協 | 148,245株 | +24.32% | 38,600株 | -47.27% | 88,763株 | +53.98% | 11,407株 | -73.43% |
2019/06/07 | 日証協 | 119,245株 | +5.02% | 73,200株 | +24.75% | 57,645株 | -8.53% | 42,934株 | +251.75% |
2019/05/31 | 日証協 | 113,545株 | +5.31% | 58,679株 | -13.45% | 63,024株 | -20.01% | 12,206株 | -26.16% |
2019/05/24 | 日証協 | 107,824株 | +24.69% | 67,800株 | +36.42% | 78,793株 | +11.67% | 16,530株 | -52.79% |
※株式分割は考慮していませんのでご注意ください。
Page Top